LDL Subclasses
Low-density lipoprotein (LDL) carries cholesterol from the liver to extrahepatic tissue. It is well accepted that increased blood concentrations of LDL-cholesterol (LDL-C) is associated with the progression of atherosclerotic cardiovascular diseases (ASCVD). Therefore, measurement of LDL-C can be considered as the most relevant marker in the risk assessment of ASCVD. Structurally, LDL are a heterogeneous population of lipoprotein particles with densities of 1.019 to 1.063 g/mL. Depending on the density, LDL can be classified into three major subclasses. LDL subclass A contains mainly larger and less dense LDL particles (densities of 1.025 – 1.034 g/mL); LDL subclass I is an intermediate group with densities of 1.034 – 1.044 g/mL; and LDL subclass B contains small and dense LDL particles (densities 1.044 – 1.060 g/mL). Small, dense LDL are better correlated with ASCVD risk than larger, less dense LDL as they can easily infiltrate into the endothelium and are more susceptible to oxidation.
Multiple studies have shown that an increased concentration of LDL subclass B is associated with an increased risk of ASCVD as compared to LDL-C alone. In addition to ultracentrifugation, LDL subclasses can be determined by and NMR spectroscopy or by using gradient gel electrophoresis. In gel electrophoresis, LDL can be separated into seven distinct subfractions (referred to as LDL-1 to LDL-7). LDL-1 and LDL-2 are defined as large LDL as they mainly contain LDL with a mean particle size of >268 Å (phenotype A). LDL-3 to LDL-7 are defined as small dense LDL with a mean particle size < 265 Å (phenotype B). Individuals with phenotype B are at higher risk of ASCVD.
- As an aid in diagnosis of atherosclerosis and cardiovascular disease
- Risk assessment for atherosclerosis and cardiovascular disease
LDL-1: < 57 mg/dL
LDL-2: <30 mg/dL
LDL-3: <6 mg/dL
LDL-4: not detected
LDL-5: not detected
LDL-6: not detected
LDL-7: not detected
Serum (SST) or Plasma (EDTA).
Stability
- Ambient: 8 hours
- Refrigerated: 5-7 days
- Frozen: unacceptable
- Atherosclerosis. 2007;192(1):211-7. [PMID: 16765964]
- Arteriosclerosis Thromb. 1992;12(2):187-95. [PMID: 1543692]
- JAMA. 1988;260(13):1917-21. [PMID: 3418853]
- Clin Chem. 2007;53(2):361-2. [PMID: 17259250]
- J Investig Med. 2013;61(6):942-9. [PMID: 23838699]
- Clin Lab Med. 2006;26(4):803-46. [PMID: 17110241]
- Clin Lab. 2009;55(11-12):421-9. [PMID: 20225664]